| Income Statement | 2025-09-30 | |||
|---|---|---|---|---|
| Revenues | 1,131,427 | |||
| Cost of goods sold | 433,196 | |||
| Gross profit | 698,231 | |||
| General and administrative expenses | 576,656 | |||
| Consulting fees | 130,357 | |||
| Total operating expenses | 707,013 | |||
| Income (loss) from operations | -8,782 | |||
| Net income (loss) | -8,782 | |||
| Net loss per common share - basic (in dollars per share) | 0 | |||
| Net loss per common share - diluted (in dollars per share) | 0 | |||
| Weighted average common shares outstanding - basic (in shares) | 10,979,055 | |||
| Weighted average common shares outstanding - diluted (in shares) | 10,979,055 | |||
BioScience Health Innovations, Inc. (BHICD)
BioScience Health Innovations, Inc. (BHICD)